J1572 HCPCS code: Injection, immune globulin, (flebogamma/flebogamma dif), intravenous, non-lyophilized (e.g., liquid), 500 mg

J1572 is the HCPCS Level II code for injection, immune globulin, (flebogamma/flebogamma dif), intravenous, non-lyophilized (e.g., liquid), 500 mg. In 2024 Medicare paid an average of $40.83 per service for J1572 across 4,241 services. Its Medicare coverage code is D (Special coverage instructions apply): May be covered when national or local coverage criteria are met. The NCCI unit limit is 180 per day on DME suppliers. Medicare volume fell 64% from 2022 to 2024 (11,660 to 4,241 services). In 2022, 2 suppliers billed Medicare for J1572 (purchases), serving 0 beneficiaries.

Code details

FieldValue
SectionJ codes — Drugs administered other than oral method
Coverage codeD — Special coverage instructions apply
Pricing indicator51 — Drug or biological (priced per ASP/average sales price rules)
BETOS categoryO1E — Other drugs
Added2008-01-01
Last action effective2009-01-01

Who bills J1572 (2022)

MeasureValue
Suppliers billing rentals—
Suppliers billing purchases2
Referring clinicians2
Medicare beneficiaries0
States with claims1

Counts only. Supplier and clinician names, contact lists and state-by-state detail are in Caduvo.

Medicare utilization for J1572, 2022–2024

YearServicesBeneficiariesAvg. allowedAvg. paid
202211,66023$37.43$29.82
20235,72017$43.10$34.64
20244,24114$51.27$40.83

NCCI unit limits (MUE)

Claim typeMax units per dayRationale
DME suppliers180Prescribing Information
outpatient hospital claims180Prescribing Information
practitioner claims180Prescribing Information

Medicare policy articles for this code

Covered diagnoses (1,217 ICD-10-CM codes)

The diagnoses most often listed as covered in the policy articles above:

ICD-10-CMDiagnosisArticles listing it
D69.3Immune thrombocytopenic purpura5
C90.00Multiple myeloma not having achieved remission4
C91.10Chronic lymphocytic leukemia of B-cell type not having achieved remission4
C91.12Chronic lymphocytic leukemia of B-cell type in relapse4
D59.0Drug-induced autoimmune hemolytic anemia4
D59.11Warm autoimmune hemolytic anemia4
D59.12Cold autoimmune hemolytic anemia4
D59.13Mixed type autoimmune hemolytic anemia4
D59.19Other autoimmune hemolytic anemia4
D69.41Evans syndrome4

Showing 10 of 1,217. The full list, non-covered diagnoses and CSV export are in Caduvo.

What changed for J1572

Frequently asked questions

What is HCPCS code J1572?

J1572 is the HCPCS Level II code for injection, immune globulin, (flebogamma/flebogamma dif), intravenous, non-lyophilized (e.g., liquid), 500 mg. Short descriptor: "Flebogamma injection".

How much does Medicare pay for J1572?

In 2024, the average Medicare payment was $40.83 per service (average allowed $51.27).

Does Medicare cover J1572?

Coverage code D — Special coverage instructions apply. May be covered when national or local coverage criteria are met.

Which diagnoses support coverage for J1572?

Medicare policy articles that cite J1572 list 1,217 covered ICD-10-CM diagnosis codes across 5 articles. The most cited include D69.3 (Immune thrombocytopenic purpura), C90.00 (Multiple myeloma not having achieved remission), C91.10 (Chronic lymphocytic leukemia of B-cell type not having achieved remission). A listed diagnosis is necessary but not sufficient; the policy's other criteria still apply.

How many units of J1572 can be billed per day?

180 on DME suppliers; 180 on outpatient hospital claims; 180 on practitioner claims (NCCI medically unlikely edits).

Related J15 codes

Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.

Next steps

Compiled by Caduvo from public CMS (Medicare) records, HCPCS release October 2026. Fees are Medicare allowables, not commercial rates. Not reviewed or endorsed by CMS. Not billing or legal advice. Report an error. Data and corrections policy.

All J codes · HCPCS lookup